NEW YORK (GenomeWeb News) – Strategic Diagnostics reported after the close of the market yesterday that its third-quarter revenues increased around 5 percent to $6.9 million from $6.6 million.
The Newark, Del.-based antibody and proteomics research products firm said that its third-quarter revenues were positively impacted by a 38 percent increase in sales of food pathogen products, a 14 percent increase in sales of water and environmental products, and a 191 percent rise in genomic antibody technology sales.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.